We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.29B
AUM Growth
+$344M
Cap. Flow
+$361M
Cap. Flow %
27.99%
Top 10 Hldgs %
48.42%
Holding
224
New
136
Increased
40
Reduced
37
Closed
9

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$25.8M
2
AFL icon
Aflac
AFL
+$20.3M
3
IBM icon
IBM
IBM
+$17.7M
4
AAPL icon
Apple
AAPL
+$14M
5
META icon
Meta Platforms (Facebook)
META
+$13.5M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$13.8M
2
PG icon
Procter & Gamble
PG
+$8M
3
T
A T & T CORP (NEW)
T
+$5.82M
4
CL icon
Colgate-Palmolive
CL
+$4.63M
5
MDT icon
Medtronic
MDT
+$3.09M

Sector Composition

Rank Sector Weight
1 Consumer Staples 32.66%
2 Healthcare 16.05%
3 Financials 9.3%
4 Technology 9.12%
5 Energy 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
51
Emerson Electric
EMR
$85B
$5.95M 0.46%
+104,991
New +$6.1M
TROW icon
52
T. Rowe Price
TROW
$26.1B
$5.66M 0.44%
+69,910
New +$5.76M
SBUX icon
53
Starbucks
SBUX
$118B
$5.59M 0.43%
118,050
-9,822
-8% -$441K
CELG
54
DELISTED
Celgene Corp
CELG
$5.37M 0.42%
+46,577
New +$5.57M
MON
55
DELISTED
Monsanto Co
MON
$5.32M 0.41%
+47,238
New +$5.61M
T icon
56
AT&T
T
$169B
$5.23M 0.41%
+212,191
New +$5.39M
GIS icon
57
General Mills
GIS
$20.1B
$5.04M 0.39%
+89,000
New +$4.75M
K
58
DELISTED
Kellanova
K
$4.95M 0.38%
79,971
+43,069
+117% +$2.63M
KLAC icon
59
KLA
KLAC
$249B
$4.9M 0.38%
+840,000
New +$5.38M
SYY icon
60
Sysco
SYY
$40.8B
$4.8M 0.37%
127,300
+18,700
+17% +$737K
ABBV icon
61
AbbVie
ABBV
$465B
$4.79M 0.37%
+81,820
New +$4.94M
NUE icon
62
Nucor
NUE
$60.5B
$4.68M 0.36%
98,389
+155
+0.2% +$7.24K
COP icon
63
ConocoPhillips
COP
$139B
$4.63M 0.36%
74,300
-10,570
-12% -$683K
CVS icon
64
CVS Health
CVS
$140B
$4.46M 0.35%
43,220
-1,940
-4% -$196K
AEP icon
65
American Electric Power
AEP
$72.4B
$4.36M 0.34%
+77,525
New +$4.6M
ZBH icon
66
Zimmer Biomet
ZBH
$18.5B
$4.25M 0.33%
37,224
+3,708
+11% +$423K
YUM icon
67
Yum! Brands
YUM
$41.4B
$4.22M 0.33%
+74,558
New +$4.07M
INTU icon
68
Intuit
INTU
$85.6B
$4.2M 0.33%
43,350
+3,000
+7% +$279K
CAT icon
69
Caterpillar
CAT
$387B
$4.14M 0.32%
51,730
+3,900
+8% +$324K
INTC icon
70
Intel
INTC
$435B
$3.99M 0.31%
+127,556
New +$4.3M
LUMN icon
71
Lumen
LUMN
$6.38B
$3.93M 0.31%
+113,807
New +$4.25M
RTX icon
72
RTX Corp
RTX
$295B
$3.9M 0.3%
52,818
-80
-0.2% -$5.97K
TMO icon
73
Thermo Fisher Scientific
TMO
$214B
$3.77M 0.29%
+28,070
New +$3.62M
ESRX
74
DELISTED
Express Scripts Holding Company
ESRX
$3.69M 0.29%
+42,581
New +$3.57M
SLB icon
75
SLB Ltd
SLB
$74.2B
$3.67M 0.28%
43,960
+960
+2% +$79.9K

Similar funds

Cullinan Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Cullinan Associates held 224 positions worth $1.29B, up 36% from $945M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cullinan Associates deployed $361M of net new capital in Q1 2015, opening 136 new positions and adding to 40 existing holdings. Its largest new stake was Chevron: 241,639 shares worth $25.4M.

By sector, the portfolio is most concentrated in Consumer Staples at 33% of assets, down from 47% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $13.8M trimmed.

  • Cullinan Associates's largest Q1 2015 buy was Chevron: 241,639 shares worth $25.4M.
  • Cullinan Associates added most to Kellanova in Q1 2015, an estimated $2.63M increase.
  • Cullinan Associates's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $13.8M.
  • Cullinan Associates fully exited A T & T CORP (NEW) in Q1 2015, selling an estimated $5.82M.
  • Cullinan Associates's ten largest holdings make up 48% of its $1.29B portfolio in Q1 2015.
  • Cullinan Associates opened 136 new positions and closed 9 in Q1 2015.
  • Cullinan Associates's portfolio value rose 36% quarter-over-quarter to $1.29B.

Based on Cullinan Associates's 13F filing for Q1 2015, filed 14 Apr 2015.